Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K23MD020429 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Minority Health and Health Disparities (NIMHD) | NIH |
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to test the feasibility and acceptability of a multi-level, community-engaged intervention to increase access to cervical cancer screening using human papillomavirus (HPV) self-collection (HPVSC) outreach among women living in a high-risk rural county and to improve navigation for follow-up screening.
A one-group intervention evaluation design will be used to pilot test feasibility and acceptability and to assess the proportion of women who return HPVSC kits and test HPV-positive. At the community level, local community-based organizations (CBOs) will serve as HPVSC kit distribution sites. At the individual level, trained community health workers will work with CBOs to support women throughout the HPVSC process, including specimen collection, kit return, result notification, and follow-up clinic-based screening for women who test HPV-positive.
The RE-AIM framework will be applied to selected domains to assess feasibility using predefined parameters. Quantitative surveys will measure acceptability of intervention components among women and community partners, and qualitative interviews will explore their experiences with the intervention.
The RE-AIM framework is a comprehensive tool for evaluating public health and community-based interventions. It focuses on five key dimensions: Reach, which assesses the number, proportion, and representativeness of individuals who participate in a program; Effectiveness, which measures the impact of the intervention on important outcomes, including potential negative effects; Adoption, which examines the number and representativeness of settings or staff that implement the program; Implementation, which evaluates how well the intervention is delivered as intended, including consistency and costs; and Maintenance, which considers the sustainability of both the intervention and its effects over time at individual and organizational levels.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Woman | Experimental | Women living in Lenoir County will receive HPV self-collection with navigation. At the community level, local community-based organizations (CBOs) will serve as human papillomavirus self-collection (HPVSC) kit distribution sites for unscreened or under screened women. |
|
| Community partners | No Intervention | Twelve community partners involved in delivering various components of the intervention (e.g., distributing self-collection kits, providing navigation to follow-up care, or providing clinic-based screening for follow-up for HPV positive tests) will complete surveys and interviews to provide feedback about the intervention. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Human papilloma virus screening | Diagnostic Test | Human papilloma virus self-collection (HPVSC) kits will be provided to screen HPV. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment and enrollment rate | Proportion of eligible unscreened women recruited, with a target enrollment of 100 participants from Lenoir County. | Up to 6 months |
| Retention rate | Ratio of returned HPV self-collection kits to kits distributed, and rate of participant withdrawal or loss to follow-up. | Up to 6 months |
| HPV positive screening rate | Rate of HPV-positive screening rate among woman started study will be reported. | Up to 6 months |
Not provided
Not provided
Woman participants
Inclusion Criteria:
Exclusion Criteria:
Community partners participants
Inclusion Criteria:
Exclusion Criteria:
• None
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lisa Mansfield, PhD, RN | Contact | (919) 966-4260 | lisa_mansfield@unc.edu |
| Name | Affiliation | Role |
|---|---|---|
| Lisa Mansfield, PhD, RN | UNC Lineberger Comprehensive Cancer Center | Principal Investigator |
Not provided
Not provided
| Label | URL |
|---|---|
| University of North Carolina Lineberger Comprehensive Cancer Center Clinical Trials | View source |
Not provided
De-identified individual participant data (IPD) generated from this study will be made publicly available. Data will be shared via unrestricted download, with no controlled access. No limitations are anticipated on data access, distribution, or reuse. All shared data will be de-identified to protect participant confidentiality and will be collected and shared in accordance with informed consent, IRB approval, and UNC Research Compliance Program policies.
Not provided
No later than the time of publication or the end of the funding period, whichever occurs first, and will be preserved for a minimum of 10 years.
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002583 | Uterine Cervical Neoplasms |
| ID | Term |
|---|---|
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
100 woman and 12 community partners will be enrolled.
Not provided
Not provided
Not provided
Not provided
| D009369 |
| Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |